Non-adherence to prescriptions is costly. Not only does it lead to poor health outcomes for patients, but it also leads to missed opportunities for pharmaceutical companies. These factors, combined with the growing opioid crisis, mean that the FDA will be implementing new requirements in the packaging of drugs, beginning with opiates. In the wake of these changes, decision makers will be forced to adjust packaging to meet new standards.
Download this playbook to receive unique insights from WestRock, one of the leading manufacturers in customized packaging who collaborated directly with the FDA in creating their designs.
In this playbook we discuss:
Thank you for your interest in the playbook! Click below to get your copy.Download Now
Enter the 6 digit code sent to your mobile number
Click on Resend the verification code again